|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-2-1
|
|
pubmed:abstractText |
The purpose of this study was to investigate in a randomized way the clinical benefit of addition of intracavitary hyperthermia (ICHT) to a conventional chemoradiotherapy schedule in patients with T2-T3N0M0 anal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
91-9
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15685041-Aged,
pubmed-meshheading:15685041-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15685041-Anus Neoplasms,
pubmed-meshheading:15685041-Combined Modality Therapy,
pubmed-meshheading:15685041-Diathermy,
pubmed-meshheading:15685041-Dose Fractionation,
pubmed-meshheading:15685041-Female,
pubmed-meshheading:15685041-Fluorouracil,
pubmed-meshheading:15685041-Humans,
pubmed-meshheading:15685041-Male,
pubmed-meshheading:15685041-Middle Aged,
pubmed-meshheading:15685041-Mitomycin,
pubmed-meshheading:15685041-Survival Analysis
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial.
|
|
pubmed:affiliation |
Aretaieion University Hospital, Radiology Department, Athens, Greece. vkouloul@cc.ece.ntua.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
